Phase 1

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(CCTG) IND.214A Phase I/II Study of MG1 Maraba/MAGE-A3 (MG1MA3), With and Without Adenovirus Vaccine, With Transgenic MAGE-A3 Insertion (AdMA3) in Patients With Incurable Advanced/Metastatic MAGE-A3-Expressing Solid TumoursHotte, Dr Sebastien OpenNCT02285816
(CCTG) IND.228A Phase II Study of Durvalumab and Tremelimumab in Patients with Advanced Rare TumoursHirte, Dr HalOpenNCT02879162
(Medivation) MDV3800-01 / TRIO031A Phase I Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800) in Patients With Advanced Solid Tumors and Normal or Varying Degrees of Renal ImpairmentHirte, Dr HalOpenNCT02997163
(Medivation) MDV3800-13A Single-Arm, Open-Label, Multicenter, Extended Treatment, Safety Study in Patients Treated With TalazoparibHirte, Dr HalOpenNCT02921919
Download PDF